Evidence map›Paper›PMID 28464477›Full record

ArticleArthritis care & research2018

Smoking Behavior Changes in the Early Rheumatoid Arthritis Period and Risk of Mortality During Thirty-Six Years of Prospective Followup.

Jeffrey A Sparks, Shun-Chiao Chang, Uyen-Sa D T Nguyen, Medha Barbhaiya, Sara K Tedeschi, Bing Lu, Karen H Costenbader, Yuqing Zhang, Hyon K Choi, Elizabeth W Karlson

Abstract read
In one paragraph

Article in Arthritis care & research, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Obstructive lung diseases and risk of rheumatoid arthritis.Expert review of clinical immunology · 2020
    Review
  12. Review
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Jeffrey A SparksBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Shun-Chiao ChangBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Uyen-Sa D T NguyenUniversity of Massachusetts School of Medicine, Worcester, and Boston University School of Medicine, Boston.
Medha BarbhaiyaBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Sara K TedeschiBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Bing LuBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Karen H CostenbaderBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.
Yuqing ZhangBoston University School of Medicine, Boston, Massachusetts.
Hyon K ChoiMassachusetts General Hospital and Harvard Medical School, Boston, Massachusetts.
Elizabeth W KarlsonBrigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts.

Funding

Long Term Multidisciplinary Study of Cancer in Women: The Nurses Health StudyUM1CA186107 · NCI · BRIGHAM AND WOMEN'S HOSPITAL · PI ELIASSEN, A. HEATHER, STAMPFER, MEIR · 2014 to 2023
$22.3M
Trial of risk mangement for prevention of accelerated atherosclerosis in SLEP60AR047782 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SOLOMON, DANIEL HAL · 2001 to 2016
$18.8M
MECHANISMS OF ARTHRITIC &DERMATOLOGY DISORDERST32AR007530 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI Michael B. Brenner, Ellen M Gravallese · 1986 to 2026
$10.4M
Novel Biomarkers and Prediction Models for Rheumatoid ArthritisR01AR049880 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI COSTENBADER, KAREN H, KARLSON, ELIZABETH W · 2003 to 2018
$8.7M
Genetic Predictors of Early Atherosclerosis in SLEK24AR052403 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI KARLSON, ELIZABETH W · 2005 to 2014
$1.5M
Rheumatoid Arthritis and Respiratory Outcomes in Prospective CohortsK23AR069688 · NIAMS · BRIGHAM AND WOMEN'S HOSPITAL · PI SPARKS, JEFFREY ANDREW · 2016 to 2020
$766k
Collider Bias and the Risk Factor Paradoxes in Rheumatic Disease ResearchK01AR064351 · NIAMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI NGUYEN, UYEN-SA DUC TRAN · 2013 to 2017
$617k
NCI NIH HHS UM1 CA186107NIAMS NIH HHS K01 AR064351NIAMS NIH HHS K23 AR069688NIAMS NIH HHS K24 AR052403NIAMS NIH HHS L30 AR066953NIAMS NIH HHS L30 AR070514NIAMS NIH HHS P60 AR047782NIAMS NIH HHS R01 AR049880NIAMS NIH HHS T32 AR007530
6 · The paper itself

Abstract

objectiveTo investigate whether rheumatoid arthritis (RA) diagnosis influences smoking behavior changes and whether these changes were associated with mortality.

methodsWe identified an incident RA cohort in the Nurses' Health Study (NHS; 1976-2012). Behavioral data were collected through biennial questionnaires. We created a comparison cohort, matching RA cases to women without RA by age and calendar year at the index date of RA diagnosis. To investigate smoking behavior changes in the early RA period, sustained cessation was defined as permanently quitting within 4 years of the RA/index date. We used Cox regression to obtain hazard ratios (HRs) for mortality, comparing sustained smoking cessation to continued smoking.

resultsAmong 121,700 women in the NHS, we identified 938 with incident RA matched to 8,951 non-RA comparators. Among current smokers, 40.0% with RA permanently quit smoking in the early RA period, compared to 36.1% of comparators (odds ratio for sustained cessation 1.18 [95% confidence interval (95% CI) 0.88, 1.58]). There were 313 deaths (33.4%) in the RA cohort and 2,042 (22.8%) among comparators. Compared to continued smoking, sustained cessation was associated with similarly decreased mortality in both the RA (HR 0.58 [95% CI 0.33, 1.01]) and comparison (HR 0.47 [95% CI 0.39, 0.58]) cohorts. Women with RA had higher mortality for >5 post-RA pack-years (HR 3.67 [95% CI 2.80, 4.81]) than comparators with >5 post-index pack-years (HR 1.88 [95% CI 1.62, 2.17]; P < 0.001 for interaction; reference: ever-smoker non-RA women with 0 post-index pack-years).

conclusionSustained smoking cessation within 4 years of RA diagnosis reduced mortality risk, with a similar effect observed among non-RA comparators. Smoking >5 pack-years after RA diagnosis significantly increased mortality beyond the risk of non-RA comparators.

Indexed as

Health BehaviorSmoking CessationAdultArthritis, RheumatoidCase-Control StudiesFemaleFollow-Up StudiesHealth Knowledge, Attitudes, PracticeHumansIncidenceMiddle AgedPrognosisProspective StudiesProtective FactorsRisk FactorsRisk Reduction Behavior

Identifiers

PMID28464477
PMCPMC5668209

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.